Загрузка...
Recombinant LH supplementation during IVF cycles with a GnRH-antagonist in estimated poor responders: A cross-matched pilot investigation of the optimal daily dose and timing
Although it is widely accepted that patients, who are considered poor responders to in vitro fertilization (IVF) benefit from recombinant luteinizing hormone (rLH) supplementation during an in vitro fertilization cycle, particularly when gonadotropin-releasing hormone (GnRH) antagonist (ant) treatme...
Сохранить в:
| Опубликовано в: : | Mol Med Rep |
|---|---|
| Главные авторы: | , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
D.A. Spandidos
2015
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4526099/ https://ncbi.nlm.nih.gov/pubmed/26059981 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mmr.2015.3904 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|